FRATES JAMES M
Insider CIK 1235598 · ALKS SVP, Alks Inc; CFO ALKS · SAGE Director · AMLX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 1,042 | $33.23 | $34.6K | 233,625 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 9,768 | $32.27 | $315.2K | 234,667 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 1,042 | $33.23 | $34.6K | 233,625 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 9,768 | $32.27 | $315.2K | 234,667 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 244,435 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 244,435 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 143,985 | — | $0 | 143,985 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-03-05 | 2026-03-09 | 95,990 | — | $0 | 261,628 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-03-02 | 2026-03-04 | 7,909 | $14.52 | $114.8K | 165,638 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-02-02 | 2026-02-04 | 3,557 | $14.65 | $52.1K | 173,547 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-06 | 2026-01-08 | 3,326 | $11.11 | $37.0K | 177,104 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-09-30 | 2025-10-02 | 10,558 | $14.65 | $154.7K | 280,430 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 19,154 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 21,500 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | U Tender | 2025-07-31 | 2025-07-31 | 2,845 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 21,500 | — | $0 | 21,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-03-31 | 2025-04-02 | 10,896 | $3.47 | $37.8K | 290,988 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2025-03-06 | 2025-03-10 | 102,630 | — | $0 | 102,630 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2025-03-06 | 2025-03-10 | 68,420 | — | $0 | 301,884 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 19,154 | — | $0 | 19,154 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | P Buy | 2024-09-12 | 2024-09-16 | 40,000 | $2.53 | $101.2K | 233,464 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-04-16 | 2024-04-18 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-04-16 | 2024-04-18 | 91,180 | — | $0 | 225,964 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-03-05 | 2024-03-07 | 1,792 | $18.73 | $33.6K | 134,784 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-02-26 | 2024-02-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-02-26 | 2024-02-28 | 40,000 | — | $0 | 152,035 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-01-09 | 2024-01-11 | 2,716 | $16.33 | $44.4K | 112,035 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-04 | 4,925 | — | $0 | 4,925 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | G Gift | 2023-10-31 | 2023-11-02 | 11,072 | — | $0 | 11,072 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-08-23 | 2024-09-05 | 18,165 | — | $0 | 363,835 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-08-23 | 2024-09-05 | 18,165 | $6.88 | $125.0K | 73,841 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-08-23 | 2023-08-24 | 18,165 | — | $0 | 363,835 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-08-23 | 2023-08-24 | 18,165 | $6.88 | $125.0K | 106,341 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-05-16 | 2023-05-18 | 32,500 | — | $0 | 382,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-05-16 | 2023-05-18 | 500 | $27.60 | $13.8K | 55,676 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-05-16 | 2023-05-18 | 32,000 | $26.93 | $861.8K | 56,176 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-05-16 | 2023-05-18 | 32,500 | $6.88 | $223.6K | 88,176 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-03-16 | 2023-03-20 | 97,500 | — | $0 | 97,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-03-16 | 2023-03-24 | 97,500 | — | $0 | 97,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-03-16 | 2023-03-24 | 32,500 | — | $0 | 414,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-03-16 | 2023-03-20 | 21,667 | — | $0 | 23,176 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 30,796 | $31.86 | $981.2K | 3,213 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 1,704 | $32.46 | $55.3K | 1,509 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-03-16 | 2023-03-24 | 32,500 | $6.88 | $223.6K | 66,509 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-24 | 30,796 | $31.86 | $981.2K | 35,713 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-24 | 1,704 | $32.46 | $55.3K | 34,009 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-03-16 | 2023-03-24 | 21,667 | — | $0 | 55,676 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 1,836 | $36.08 | $66.2K | 34,831 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 822 | $36.79 | $30.2K | 34,009 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2022-12-30 | 2023-01-04 | 5,000 | — | $0 | 447,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2022-12-30 | 2023-01-04 | 5,000 | $6.88 | $34.4K | 36,667 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 9,947 | — | $0 | 9,947 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-02-11 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2023-04-26 | 19,482 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2023-04-26 | 19,482 | — | $0 | 19,482 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-01-06 | 2022-01-10 | 142,500 | — | $0 | 142,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2022-01-06 | 2022-01-10 | 31,667 | — | $0 | 31,667 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | P Buy | 2021-06-16 | 2021-06-17 | 1,810 | $55.10 | $99.7K | 1,810 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-05-14 | 2020-05-14 | 21,983 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-05-14 | 2020-05-14 | 21,983 | $11.74 | $258.1K | 91,828 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-03-01 | 2020-03-03 | 4,500 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-03-01 | 2020-03-03 | 4,500 | — | $0 | 71,168 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-03-01 | 2020-03-03 | 1,323 | $20.84 | $27.6K | 69,845 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-02-21 | 2020-02-24 | 5,825 | — | $0 | 17,475 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-02-21 | 2020-02-24 | 1,712 | $20.24 | $34.7K | 66,668 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-02-21 | 2020-02-24 | 5,825 | — | $0 | 68,380 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-02-20 | 2020-02-24 | 24,474 | — | $0 | 24,474 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-02-20 | 2020-02-24 | 102,337 | — | $0 | 102,337 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-02-17 | 2020-02-18 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-02-17 | 2020-02-18 | 904 | $17.77 | $16.1K | 62,555 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-02-17 | 2020-02-18 | 3,000 | — | $0 | 63,459 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-02-16 | 2020-02-18 | 3,375 | — | $0 | 6,750 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-02-16 | 2020-02-18 | 3,375 | — | $0 | 61,631 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-02-16 | 2020-02-18 | 1,172 | $17.77 | $20.8K | 60,459 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-09-13 | 2019-09-17 | 20,000 | — | $0 | 21,983 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-09-13 | 2019-09-17 | 20,000 | $11.74 | $234.8K | 58,256 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-16 | 8,000 | — | $0 | 5,922 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2019-08-15 | 2019-08-16 | 8,000 | $160.58 | $1.28M | 2,535 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2019-08-15 | 2019-08-16 | 8,000 | $28.35 | $226.8K | 10,535 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | G Gift | 2019-05-06 | 2019-08-16 | 500 | — | $0 | 2,535 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | G Gift | 2019-05-06 | 2019-08-16 | 1,200 | — | $0 | 3,035 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2019-05-06 | 2019-05-06 | 8,000 | — | $0 | 1,309 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2019-05-06 | 2019-05-06 | 8,000 | $8.92 | $71.4K | 12,235 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2019-05-06 | 2019-05-06 | 8,000 | $162.22 | $1.30M | 4,235 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-03-01 | 2019-03-04 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-03-01 | 2019-03-04 | 1,323 | $34.44 | $45.6K | 49,721 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-03-01 | 2019-03-04 | 4,500 | — | $0 | 51,044 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-02-26 | 2019-02-27 | 2,625 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-02-26 | 2019-02-27 | 2,625 | — | $0 | 47,316 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-02-26 | 2019-02-27 | 772 | $33.92 | $26.2K | 46,544 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 23,300 | — | $0 | 23,300 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 90,600 | — | $0 | 90,600 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-02-17 | 2019-02-19 | 3,000 | — | $0 | 6,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-02-17 | 2019-02-19 | 875 | $32.54 | $28.5K | 44,691 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-02-17 | 2019-02-19 | 3,000 | — | $0 | 45,566 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-02-16 | 2019-02-19 | 3,375 | — | $0 | 10,125 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-02-16 | 2019-02-19 | 3,375 | — | $0 | 43,664 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-02-16 | 2019-02-19 | 1,098 | $32.54 | $35.7K | 42,566 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2019-01-23 | 2019-01-24 | 7,500 | — | $0 | 9,309 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2019-01-23 | 2019-01-24 | 7,500 | $134.81 | $1.01M | 4,235 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2019-01-23 | 2019-01-24 | 7,500 | $8.92 | $66.9K | 11,735 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2018-12-07 | 2018-12-11 | 5,500 | — | $0 | 42,734 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-12-07 | 2018-12-11 | 2,445 | $34.01 | $83.2K | 40,289 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | G Gift | 2018-08-22 | 2018-08-23 | 700 | — | $0 | 4,300 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | G Gift | 2018-08-22 | 2018-08-23 | 65 | — | $0 | 4,235 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-06-12 | 2018-06-13 | 16,842 | $50.00 | $842.1K | 37,234 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2018-06-06 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2018-05-08 | 2018-05-08 | 7,000 | — | $0 | 16,809 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2018-05-08 | 2018-05-08 | 7,000 | $154.00 | $1.08M | 5,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2018-05-08 | 2018-05-08 | 7,000 | $8.92 | $62.4K | 12,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-03-03 | 2018-03-05 | 2,813 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-03-03 | 2018-03-05 | 1,029 | $60.05 | $61.8K | 84,340 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-03-03 | 2018-03-05 | 2,813 | — | $0 | 85,369 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 4,500 | — | $0 | 9,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-03-01 | 2018-03-05 | 1,326 | $57.41 | $76.1K | 82,556 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-03-01 | 2018-03-05 | 4,500 | — | $0 | 83,882 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-02-26 | 2018-02-28 | 2,625 | — | $0 | 2,625 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-02-26 | 2018-02-28 | 2,625 | — | $0 | 80,156 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-02-26 | 2018-02-28 | 774 | $58.12 | $45.0K | 79,382 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-02-17 | 2018-02-21 | 3,000 | — | $0 | 9,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-02-17 | 2018-02-21 | 3,000 | — | $0 | 147,039 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-02-17 | 2018-02-21 | 929 | $67.26 | $62.5K | 146,110 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-02-16 | 2018-02-21 | 54,500 | — | $0 | 54,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-02-16 | 2018-02-21 | 13,500 | — | $0 | 13,500 | SEC↗ |
| ALKS Alkermes plc. | G Gift | 2017-12-15 | 2019-09-17 | 2,000 | — | $0 | 38,256 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-11-29 | 2017-11-30 | 20,932 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-11-29 | 2017-11-30 | 20,532 | $50.49 | $1.04M | 144,439 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-11-29 | 2017-11-30 | 400 | $51.25 | $20.5K | 144,039 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-11-29 | 2017-11-30 | 20,932 | $12.29 | $257.3K | 164,971 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-11-08 | 2017-11-09 | 20,932 | — | $0 | 20,932 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-11-08 | 2017-11-09 | 20,932 | $12.29 | $257.3K | 164,971 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-11-08 | 2017-11-09 | 20,932 | $47.58 | $995.9K | 144,039 | SEC↗ |
| ALKS Alkermes plc. | G Gift | 2017-06-09 | 2017-11-09 | 2,000 | — | $0 | 127,477 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2017-06-07 | 2017-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-05-28 | 2017-05-30 | 2,500 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-05-28 | 2017-05-30 | 1,177 | $57.70 | $67.9K | 129,477 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-05-28 | 2017-05-30 | 2,500 | — | $0 | 130,654 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-03-07 | 2017-03-07 | 25,000 | — | $0 | 68,958 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-03-07 | 2017-03-07 | 400 | $59.57 | $23.8K | 119,053 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-03-07 | 2017-03-07 | 24,600 | $59.07 | $1.45M | 119,453 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-03-07 | 2017-03-07 | 25,000 | $16.55 | $413.8K | 144,053 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-03-03 | 2017-03-06 | 2,812 | — | $0 | 2,813 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-03-03 | 2017-03-06 | 2,812 | — | $0 | 119,966 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-03-03 | 2017-03-06 | 913 | $60.97 | $55.7K | 119,053 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-03-01 | 2017-03-02 | 4,500 | — | $0 | 13,500 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-03-01 | 2017-03-02 | 1,461 | $59.71 | $87.2K | 117,154 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-03-01 | 2017-03-02 | 4,500 | — | $0 | 118,615 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-02-26 | 2017-02-27 | 2,625 | — | $0 | 5,250 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-02-26 | 2017-02-27 | 852 | $52.98 | $45.1K | 114,115 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-02-26 | 2017-02-27 | 2,625 | — | $0 | 114,967 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2017-02-17 | 2017-02-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2017-02-17 | 2017-02-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-12-14 | 2016-12-15 | 10,000 | — | $0 | 41,983 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-12-14 | 2016-12-15 | 15,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-12-14 | 2016-12-15 | 10,000 | $11.74 | $117.4K | 137,342 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-12-14 | 2016-12-15 | 15,000 | $14.13 | $211.9K | 127,342 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-12-14 | 2016-12-15 | 24,900 | $54.72 | $1.36M | 112,442 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-12-14 | 2016-12-15 | 100 | $55.20 | $5.5K | 112,342 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-12-07 | 2016-12-08 | 13,731 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-12-07 | 2016-12-08 | 10,000 | — | $0 | 51,983 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-12-07 | 2016-12-08 | 17,379 | $56.44 | $980.9K | 113,198 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-12-07 | 2016-12-08 | 13,731 | $15.95 | $219.0K | 126,073 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-12-07 | 2016-12-08 | 10,000 | $11.74 | $117.4K | 136,073 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-12-07 | 2016-12-08 | 856 | $57.22 | $49.0K | 112,342 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-12-07 | 2016-12-08 | 5,496 | $55.65 | $305.9K | 130,577 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-11-18 | 2016-11-21 | 6,042 | — | $0 | 93,958 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2016-11-18 | 2016-11-21 | 1,711 | $58.44 | $100.0K | 93,763 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-11-18 | 2016-11-21 | 6,042 | $16.55 | $100.0K | 95,474 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-10-05 | 2016-10-06 | 5,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2016-10-05 | 2016-10-06 | 2,353 | $46.43 | $109.2K | 89,432 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-10-05 | 2016-10-06 | 5,000 | — | $0 | 91,785 | SEC↗ |
| ALKS Alkermes plc. | G Gift | 2016-08-04 | 2016-10-06 | 4,437 | — | $0 | 61,924 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 13,922 | $28.35 | $394.7K | 13,922 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-05-28 | 2016-06-01 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2016-05-28 | 2016-06-01 | 1,177 | $46.13 | $54.3K | 56,601 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-05-28 | 2016-06-01 | 2,500 | — | $0 | 57,778 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-05-21 | 2016-05-23 | 3,750 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-05-21 | 2016-05-23 | 3,750 | — | $0 | 56,537 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2016-05-21 | 2016-05-23 | 1,259 | $42.98 | $54.1K | 55,278 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-03-03 | 2016-03-04 | 2,813 | — | $0 | 5,625 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-03-03 | 2016-03-04 | 23,315 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-03-03 | 2016-03-04 | 23,315 | $20.79 | $484.7K | 49,974 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-03-03 | 2016-03-04 | 2,813 | — | $0 | 52,787 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2016-02-29 | 2016-03-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2016-02-29 | 2016-03-01 | 76,000 | — | $0 | 76,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-02-26 | 2016-03-01 | 2,625 | — | $0 | 7,875 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-02-26 | 2016-03-01 | 2,625 | — | $0 | 26,659 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-11-24 | 2015-11-24 | 5,523 | — | $0 | 94,477 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-11-24 | 2015-11-24 | 5,523 | $18.11 | $100.0K | 55,380 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2015-11-24 | 2015-11-24 | 1,346 | $74.26 | $100.0K | 54,034 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-11-10 | 2015-11-12 | 10,000 | — | $0 | 13,731 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-11-10 | 2015-11-12 | 10,000 | $15.95 | $159.5K | 59,857 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-11-10 | 2015-11-12 | 10,000 | $72.34 | $723.4K | 49,857 | SEC↗ |
| ALKS Alkermes plc. | G Gift | 2015-11-04 | 2015-11-12 | 1,500 | — | $0 | 49,857 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-10-13 | 2015-10-14 | 10,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-10-13 | 2015-10-14 | 10,000 | — | $0 | 61,983 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-10-13 | 2015-10-14 | 10,000 | $11.74 | $117.4K | 71,357 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-10-13 | 2015-10-14 | 10,000 | $14.38 | $143.8K | 61,357 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-10-13 | 2015-10-14 | 5,949 | $60.20 | $358.1K | 55,703 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-10-13 | 2015-10-14 | 9,705 | $59.09 | $573.5K | 61,652 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-10-13 | 2015-10-14 | 4,346 | $60.72 | $263.9K | 51,357 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2015-10-05 | 2015-10-07 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2015-10-05 | 2015-10-07 | 2,356 | $59.77 | $140.8K | 51,357 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2015-10-05 | 2015-10-07 | 5,000 | — | $0 | 53,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-09-15 | 2015-09-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-09-15 | 2015-09-15 | 10,000 | — | $0 | 71,983 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-09-15 | 2015-09-15 | 10,000 | $14.38 | $143.8K | 68,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-09-15 | 2015-09-15 | 10,000 | $11.74 | $117.4K | 58,713 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-09-15 | 2015-09-15 | 10,800 | $70.85 | $765.2K | 57,913 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-09-15 | 2015-09-15 | 9,200 | $71.39 | $656.8K | 48,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-08-11 | 2015-08-12 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-08-11 | 2015-08-12 | 6,926 | $68.13 | $471.9K | 48,713 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-08-11 | 2015-08-12 | 3,074 | $67.63 | $207.9K | 55,639 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-08-11 | 2015-08-12 | 10,000 | $14.38 | $143.8K | 58,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-07-14 | 2015-07-15 | 10,000 | — | $0 | 30,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-07-14 | 2015-07-15 | 10,000 | — | $0 | 81,983 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-07-14 | 2015-07-15 | 8,485 | $66.37 | $563.1K | 48,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-07-14 | 2015-07-15 | 10,000 | $11.74 | $117.4K | 68,713 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-07-14 | 2015-07-15 | 11,515 | $65.37 | $752.7K | 57,198 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-07-14 | 2015-07-15 | 10,000 | $14.38 | $143.8K | 58,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-06-16 | 2015-06-18 | 10,000 | — | $0 | 91,983 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-06-16 | 2015-06-18 | 10,000 | $11.74 | $117.4K | 58,713 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-06-16 | 2015-06-18 | 10,000 | $58.63 | $586.3K | 48,713 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2015-05-28 | 2015-05-29 | 13,922 | $73.13 | $1.02M | 13,922 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-05-28 | 2015-06-01 | 2,500 | — | $0 | 5,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2015-05-28 | 2015-06-01 | 1,178 | $59.92 | $70.6K | 48,713 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-05-28 | 2015-06-01 | 2,500 | — | $0 | 85,115 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-05-21 | 2015-05-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-05-21 | 2015-05-22 | 3,750 | — | $0 | 84,382 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2015-05-21 | 2015-05-22 | 1,767 | $61.80 | $109.2K | 82,615 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-05-20 | 2015-05-22 | 3,750 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-05-20 | 2015-05-22 | 3,750 | — | $0 | 82,399 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2015-05-20 | 2015-05-22 | 1,767 | $62.10 | $109.7K | 80,632 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-05-12 | 2015-05-13 | 10,000 | — | $0 | 101,983 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-05-12 | 2015-05-13 | 10,000 | $59.34 | $593.4K | 78,649 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-05-12 | 2015-05-13 | 10,000 | $11.74 | $117.4K | 88,649 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-04-15 | 2015-04-17 | 10,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-04-15 | 2015-04-17 | 10,000 | $62.42 | $624.2K | 78,649 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-04-15 | 2015-04-17 | 10,000 | $9.21 | $92.1K | 88,649 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-03-10 | 2015-03-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-03-10 | 2015-03-11 | 10,000 | $9.21 | $92.1K | 88,649 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-03-10 | 2015-03-11 | 1,400 | $66.87 | $93.6K | 78,649 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-03-10 | 2015-03-11 | 8,600 | $66.15 | $568.9K | 80,049 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-03-03 | 2015-03-05 | 2,812 | — | $0 | 8,438 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-03-03 | 2015-03-05 | 2,812 | — | $0 | 79,974 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2015-03-03 | 2015-03-05 | 1,325 | $72.80 | $96.5K | 78,649 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2015-02-26 | 2015-02-27 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2015-02-26 | 2015-02-27 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-02-03 | 2015-02-04 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-02-03 | 2015-02-04 | 10,000 | $9.21 | $92.1K | 87,162 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-02-03 | 2015-02-04 | 6,800 | $70.39 | $478.7K | 80,362 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-02-03 | 2015-02-04 | 1,000 | $72.49 | $72.5K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-02-03 | 2015-02-04 | 2,200 | $71.43 | $157.1K | 78,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2015-01-15 | 2015-01-16 | 10,000 | — | $0 | 30,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-01-15 | 2015-01-16 | 5,700 | $66.55 | $379.3K | 81,462 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-01-15 | 2015-01-16 | 500 | $68.12 | $34.1K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2015-01-15 | 2015-01-16 | 3,800 | $67.17 | $255.2K | 77,662 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2015-01-15 | 2015-01-16 | 10,000 | $9.21 | $92.1K | 87,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-12-10 | 2014-12-11 | 8,870 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-12-10 | 2014-12-11 | 10,000 | — | $0 | 40,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-12-10 | 2014-12-11 | 10,000 | $9.21 | $92.1K | 96,032 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-12-10 | 2014-12-11 | 8,870 | $14.90 | $132.2K | 86,032 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2014-12-10 | 2014-12-11 | 18,170 | $56.04 | $1.02M | 77,862 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2014-12-10 | 2014-12-11 | 700 | $56.65 | $39.7K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-12-03 | 2014-12-05 | 8,000 | — | $0 | 8,870 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-12-03 | 2014-12-05 | 8,000 | $14.90 | $119.2K | 85,162 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2014-12-03 | 2014-12-05 | 8,000 | $55.72 | $445.8K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-11-19 | 2014-11-21 | 8,000 | — | $0 | 16,870 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-11-19 | 2014-11-21 | 8,000 | $14.90 | $119.2K | 85,162 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2014-11-19 | 2014-11-21 | 8,000 | $53.86 | $430.9K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-11-07 | 2014-11-07 | 8,000 | — | $0 | 24,870 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-11-07 | 2014-11-07 | 5,303 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-11-07 | 2014-11-07 | 5,303 | $8.55 | $45.3K | 82,465 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2014-11-07 | 2014-11-07 | 763 | $49.98 | $38.1K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-11-07 | 2014-11-07 | 8,000 | $14.90 | $119.2K | 90,465 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2014-11-07 | 2014-11-07 | 12,540 | $49.98 | $626.7K | 77,925 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-31 | 2014-11-04 | 11,697 | — | $0 | 5,303 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-31 | 2014-11-04 | 5,376 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-31 | 2014-11-04 | 6,269 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-31 | 2014-11-04 | 4,810 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-31 | 2014-11-04 | 8,517 | — | $0 | 111,983 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-31 | 2014-11-04 | 8,136 | — | $0 | 41,864 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2014-10-31 | 2014-11-04 | 1,978 | $50.55 | $100.0K | 77,162 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-10-31 | 2014-11-04 | 11,697 | $8.55 | $100.0K | 79,140 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2014-10-31 | 2014-11-04 | 1,978 | $50.55 | $100.0K | 67,443 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-10-31 | 2014-11-04 | 4,810 | $20.79 | $100.0K | 69,421 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2014-10-31 | 2014-11-04 | 1,978 | $50.55 | $100.0K | 64,611 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-10-31 | 2014-11-04 | 8,517 | $11.74 | $100.0K | 66,589 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2014-10-31 | 2014-11-04 | 1,978 | $50.55 | $100.0K | 58,072 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-10-31 | 2014-11-04 | 8,136 | $12.29 | $100.0K | 60,050 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2014-10-31 | 2014-11-04 | 1,978 | $50.55 | $100.0K | 51,914 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-10-31 | 2014-11-04 | 6,269 | $15.95 | $100.0K | 53,892 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2014-10-31 | 2014-11-04 | 1,978 | $50.55 | $100.0K | 47,623 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2014-10-31 | 2014-11-04 | 5,376 | $18.60 | $100.0K | 49,601 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2014-10-08 | 2014-10-10 | 8,000 | — | $0 | 17,000 | SEC↗ |